RxDoctor Payments Data

Joye Lowman, MD

Urogynecology and Reconstructive Pelvic Surgery · Atlanta, GANPI 1447418843

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (52.1%), travel and lodging and education — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Medtronic at 34.7% of the total.

$9,782in general payments, 2019–2025

Across 108 payments — averaging $90.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$3K
  • Coloplast$3K
  • Applied Medical Resources Corporation$2K
  • Boston Scientific$939
  • Astellas Pharma US Inc$251
  • Caldera Medical, Inc$247
  • plus $783 from 10 others

What the payments were for

  • Travel & lodging$4,51246%
  • Food & beverage$5,09952%
  • Education$1001%
  • Gifts$711%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,782 in reported general payments places this provider in the 70th percentile of 32 urogynecology and reconstructive pelvic surgery providers in Georgia.

See all urogynecology and reconstructive pelvic surgery providers in Georgia

Medicare billing

Part B allowed, 2024
$79,398
Medicare patients
170
Services billed
571

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol224$12,752
GemtesaVibegron12$7,479
Solifenacin Succinate108$4,263
Trospium Chloride64$3,153
Oxybutynin Chloride ErOxybutynin Chloride87$1,923
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst63$1,078
Tolterodine Tartrate ErTolterodine Tartrate15$445
Amitriptyline Hcl20$196
Nystatin-TriamcinoloneNystatin/Triamcinolone Acet11$186
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen23$151
Fluconazole15$139
Ciprofloxacin Hcl41$127
Ibuprofen25$61

Paid to pharmacies, not to this prescriber.

Other urogynecology and reconstructive pelvic surgery in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →